2 weeks Ago By Defense World Staff
Biora Therapeutics ( NASDAQ:BIOR – Get Free Report ) will be issuing its quarterly earnings data after the market closes on Thursday, November 14th. Analysts expect the company to announce earnings of ($3.85) per share for the quarter.
Individual interested in participating in the company’s earnings conference call can do so using this link . Biora Therapeutics ( NASDAQ:BIOR – Get Free Report ) last issued its earnings results on Monday, August 12th. The company reported ($3.
50) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.50) by $1.00.
The company had revenue of $0.32 million during the quarter. On average, analysts expect Biora Therapeutics to post $-12 EPS for the current fiscal year and $-12 EPS for the next fiscal year.
Biora Therapeutics Price Performance Shares of NASDAQ:BIOR opened at $2.70 on Wednesday. Biora Therapeutics has a 12 month low of $2.
38 and a 12 month high of $19.90. The firm has a market capitalization of $9.
93 million, a P/E ratio of -0.05 and a beta of 1.27.
The company’s fifty day moving average price is $4.98 and its 200 day moving average price is $6.12.
Analyst Upgrades and Downgrades View Our Latest Report on Biora Therapeutics Biora Therapeutics Company Profile ( Get Free Report ) Biora Therapeutics, Inc, a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. Featured Stories Five stocks we like better than Biora Therapeutics Stock Trading Terms – Stock Terms Every Investor Needs to Know Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025 3 Home Improvement Stocks that Can Upgrade Your Portfolio Is Tesla’s Valuation a Bubble or Backed by Real Growth? Earnings Per Share Calculator: How to Calculate EPS Trucking Stocks Led the Pack Last Week: Can They Keep Rolling? Receive News & Ratings for Biora Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biora Therapeutics and related companies with MarketBeat.
com's FREE daily email newsletter ..
